• 1
    Gavras I, Gavras H. Angiotensin II as a cardiovascular risk factor. J Hum Hypertens 2002; 16: S2S6.
  • 2
    Hughes AD. AT(1)-signaling in vascular smooth muscle. J Renin Angiotensin Aldosterone Syst 2000; 1: 125130.
  • 3
    Jonsson JR, Clouston AD, Ando Y, Kelemen LI, Horn MJ, Adamson MD, et al. Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology 2001; 121: 148155.
  • 4
    Sun Y, Weber KT. Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart. J Mol Cell Cardiol 1996; 28: 851858.
  • 5
    Sun Y, Weber KT. Cells expressing angiotensin II receptors in fibrous tissue of rat heart. Cardiovasc Res 1996; 31: 518525.
  • 6
    De BK, Bandyopadhyay K, Das TK, Das D, Biswas PK, Majumdar D, et al. Portal pressure response to losartan compared with propranolol in patients with cirrhosis. Am J Gastroenterol 2003; 98: 13711376.
    Direct Link:
  • 7
    Terui Y, Saito T, Watanabe H, Togashi H, Kawata S, Kamada Y, et al. Effect of angiotensin receptor antagonist on liver fibrosis in early stages of chronic hepatitis C. HEPATOLOGY 2002; 36: 1022.
  • 8
    Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J. Inflammation and angiotensin II. Int J Biochem Cell Biol 2003; 35: 881900.
  • 9
    Luft FC, Mervaala E, Muller DN, Gross V, Schmidt F, Park JK, et al. Hypertension-induced end-organ damage: a new transgenic approach to an old problem. Hypertension 1999; 33: 212218.
  • 10
    Pueyo ME, Gonzalez W, Nicoletti A, Savoie F, Arnal JF, Michel JB. Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol 2000; 20: 645651.
  • 11
    Ruiz-Ortega M, Lorenzo O, Ruperez M, Blanco J, Egido J. Systemic infusion of angiotensin II into normal rats activates nuclear factor-kappaB and AP-1 in the kidney: role of AT(1) and AT(2) receptors. Am J Pathol 2001; 158: 17431756.
  • 12
    Harrison DG, Cai H, Landmesser U, Griendling KK. Interactions of angiotensin II with NAD(P)H oxidase, oxidant stress and cardiovascular disease. J Renin Angiotensin Aldosterone Syst 2003; 4: 5161.
  • 13
    Bataller R, Gabele E, Schoonhoven R, Morris T, Lehnert M, Yang L, et al. Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver. Am J Physiol Gastrointest Liver Physiol 2003; 285: G642G651.
  • 14
    Bataller R, Schwabe RF, Choi YH, Yang L, Paik YH, Lindquist J, et al. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 2003; 112: 13831394.
  • 15
    Leung PS, Suen PM, Ip SP, Yip CK, Chen G, Lai PB. Expression and localization of AT1 receptors in hepatic Kupffer cells: its potential role in regulating a fibrogenic response. Regul Pept 2003; 116: 6169.
  • 16
    Grasl-Kraupp B, Ruttkay-Nedecky B, Koudelka H, Bukowska K, Bursch W, Schulte-Hermann R. In situ detection of fragmented DNA (TUNEL assay) fails to discriminate among apoptosis, necrosis, and autolytic cell death: a cautionary note. HEPATOLOGY 1995; 21: 14651468.
  • 17
    McKim S, Konno A, Gabele E, Uesugi T, Froh M, Sies H, et al. Cocoa extract protects against early alcohol-induced liver injury in the rat. Arch Biochem Biophys 2002; 406: 4046.
  • 18
    Gujral JS, Liu J, Farhood A, Hinson JA, Jaeschke H. Functional importance of ICAM-1 in the mechanism of neutrophil-induced liver injury in bile duct-ligated mice. Am J Physiol Gastrointest Liver Physiol 2004; 286: G499G507.
  • 19
    Liu P, Xu B, Hock CE, Nagele R, Sun FF, Wong PY. NO modulates P-selectin and ICAM-1 mRNA expression and hemodynamic alterations in hepatic I/R. Am J Physiol 1998; 275: H2191H2198.
  • 20
    Zhong Z, Froh M, Connor HD, Li X, Conzelmann LO, Mason RP, et al. Prevention of hepatic ischemia-reperfusion injury by green tea extract. Am J Physiol Gastrointest Liver Physiol 2002; 283: G957G964.
  • 21
    Bradford BU, Marotto ME, Lemasters JJ, Thurman RG. New, simple models to evaluate zone-specific damage due to hypoxia in the perfused rat liver: time course and effect of nutritional state. J Pharmacol Exp Therapeut 1986; 236: 263268.
  • 22
    McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312: 159163.
  • 23
    McCord JM, Fridovich I. The reduction of cytochrome C by milk xanthine oxidase. J Biol Chem 1968; 243: 57535760.
  • 24
    Jaeschke H. Molecular mechanisms of hepatic ischemia-reperfusion injury and preconditioning. Am J Physiol Gastrointest Liver Physiol 2003; 284: G15G26.
  • 25
    Farhood A, McGuire GM, Manning AM, Miyasaka M, Smith CW, Jaeschke H. Intracellular adhesion molecule 1 (ICAM-1) expression and its role in neutrophil-induced ischemia-reperfusion injury in rat liver. J Leukoc Biol 1995; 57: 368374.
  • 26
    Yadav SS, Howell DN, Gao W, Steeber DA, Harland RC, Clavien PA. L-selectin and ICAM-1 mediate reperfusion injury and neutrophil adhesion in the warm ischemic mouse liver. Am J Physiol 1998; 275: G1341G1352.
  • 27
    Soden M, Klett C, Hasmann T, Hackenthal E. Angiotensinogen: an acute-phase protein? Hypertension 1994; 23: I126I130.
  • 28
    Masuko H, Jin MB, Horiuchi H, Suzuki T, Taniguchi M, Shimamura T, et al. Protective effect of agiotensin II type I receptor antagonist, CV-11974, on ischemia and reperfusion injury of the liver. Transplantation 2001; 71: 10341039.
  • 29
    Bailey RW, Brengman ML, Fuh KC, Hamilton SR, Herlong HF, Bulkley GB. Hemodynamic pathogenesis of ischemic hepatic injury following cardiogenic shock/resuscitation. Shock 2000; 14: 451459.
  • 30
    Lemaster JJ, Thurman RG. Hypoxia and reperfusion injury to liver. Prog Liver Dis 1993; 11: 85114.
  • 31
    Aruoma OI, Akanmu D, Cecchini R, Halliwell B. Evaluation of the ability of the angiotensin-converting enzyme inhibitor captopril to scavenge reactive oxygen species. Chem Biol Interact 1991; 77: 303314.
  • 32
    Sies H. Strategies of antioxidant defense. Eur J Biochem 1993; 215: 213219.